HYDROXYZINE HYDROCHLORIDE INJECTION, USP 50 MG
HYDROXYZINE HYDROCHLORIDE : 50 MG · DIN 02231209 · STERIMAX INC
Health Canada status: DORMANT
What is HYDROXYZINE HYDROCHLORIDE INJECTION, USP?
HYDROXYZINE HYDROCHLORIDE INJECTION, USP 50 MG contains HYDROXYZINE HYDROCHLORIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02231209, held by STERIMAX INC, supplied as SOLUTION for INTRAMUSCULAR administration. Health Canada currently lists it as dormant, status dated 03-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is HYDROXYZINE HYDROCHLORIDE INJECTION, USP called?
Also recorded in Canada as: 2 ML hydroxyzine hydrochloride 50 MG/ML Injection (US), 1 ML hydroxyzine hydrochloride 50 MG/ML Injection (US), hydroxyzine hydrochloride 10 MG Oral Tablet (US), hydroxyzine hydrochloride 100 MG Oral Tablet (US), hydroxyzine hydrochloride 2 MG/ML Oral Solution (US), hydroxyzine hydrochloride 25 MG Oral Tablet (US), 1 ML hydroxyzine hydrochloride 25 MG/ML Injection (US), hydroxyzine hydrochloride 50 MG Oral Tablet (US), hydroxyzine hydrochloride 50 MG/ML Injectable Solution (US), HYDROXYZINE HYDROCHLORIDE (US), HYDROXYZINE HYDROCHLORIDE ORAL (US), Vistaril (US), Atarax (US), Atarax (EU), Atarax (UK).
The same molecule, HYDROXYZINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| ATARAX | Latin | Morocco |
| Aterax | Latin | South Africa |
| Aterax Syrup | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02231209 |
|---|---|
| Brand name | HYDROXYZINE HYDROCHLORIDE INJECTION, USP |
| Generic / active ingredient | HYDROXYZINE HYDROCHLORIDE : 50 MG |
| Manufacturer | STERIMAX INC |
| Strength | 50 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | N05BB01 HYDROXYZINE |
| AHFS class | 88:28.01* ; See footnote |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 03-Aug-2017 |
| Original market date | 1997-12-01 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02231209 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2231209 |
| Brand name | HYDROXYZINE HYDROCHLORIDE INJECTION, USP |
| Active ingredient / INN | HYDROXYZINE HYDROCHLORIDE : 50 MG |
| ATC code | N05BB01 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05 |
| AHFS class | 88:28.01* ; See footnote |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | STERIMAX INC |
Which pack is which?
| Strength on the label | 50 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is HYDROXYZINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by AA PHARMA INC, last seen 16 Jun 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for HYDROXYZINE HYDROCHLORIDE INJECTION, USP
What can be used instead?
Other Canadian products sharing ATC code N05BB01 HYDROXYZINE. 5 of 29 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ATARAX | 10 MG / 5 ML | SYRUP | SEARCHLIGHT PHARMA INC | MARKETED | DIN 00024694 |
| HYDROXYZINE | 10 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 00646059 |
| HYDROXYZINE | 25 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 00646024 |
| HYDROXYZINE | 50 MG | CAPSULE | AA PHARMA INC | MARKETED | DIN 00646016 |
| HYDROXYZINE HYDROCHLORIDE INJECTION USP | 50 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00742813 |
| ATARAX CAP 10MG | 10 MG | CAPSULE | ERFA CANADA 2012 INC | CANCELLED POST MARKET | DIN 00024376 |
| ATARAX CAP 25MG | 25 MG | CAPSULE | ERFA CANADA 2012 INC | CANCELLED POST MARKET | DIN 00024384 |
| ATARAX CAP 50MG | 50 MG | CAPSULE | ERFA CANADA 2012 INC | CANCELLED POST MARKET | DIN 00024392 |
| ATARAX IM SOL 50MG/ML | 50 MG | SOLUTION | ERFA CANADA 2012 INC | CANCELLED POST MARKET | DIN 00024589 |
| HYDROXYZINE HYDROCHLORIDE INJECTION | 50 MG | LIQUID | FRESENIUS KABI CANADA LTD | CANCELLED PRE MARKET | DIN 02242864 |
Who else supplies HYDROXYZINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. HYDROXYZINE appears in 24 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does HYDROXYZINE cost around the world?
HYDROXYZINE is listed on 5 national price registers Nexara tracks, across 86 pack listings published on 5 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 5 | 72 | 03 Sep 2026 |
| South Africa | single exit price | 5 | 6 | 01 Sep 2026 |
| Greece | producer price (ex-factory) | 4 | 4 | 03 Sep 2026 |
| Morocco | PPV (public price) | 1 | 3 | 05 Sep 2026 |
| United Kingdom | hospital | 1 | 1 | 31 Aug 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.